再生医学の世界市場:技術別(幹細胞療法、バイオマテリアル、組織工学、その他)、用途別(骨移植代用品、骨関節疾患、皮膚病学、心血管、中枢神経系、その他)、地域別予測

◆英語タイトル:Global Regenerative Medicine Market Size study, by Technology (Stem Cell Therapy, Biomaterial, Tissue Engineering, Others), by Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System, Others) and Regional Forecasts 2019-2026
◆商品コード:BZW9JN105
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2019年6月25日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥426,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD5,550 ⇒換算¥599,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、再生医学の世界市場について調べ、再生医学の世界規模、市場動向、市場環境、技術別(幹細胞療法、バイオマテリアル、組織工学、その他)分析、用途別(骨移植代用品、骨関節疾患、皮膚病学、心血管、中枢神経系、その他)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・再生医学の世界市場概要
・再生医学の世界市場環境
・再生医学の世界市場動向
・再生医学の世界市場規模
・再生医学の世界市場規模:技術別(幹細胞療法、バイオマテリアル、組織工学、その他)
・再生医学の世界市場規模:用途別(骨移植代用品、骨関節疾患、皮膚病学、心血管、中枢神経系、その他)
・再生医学の世界市場:地域別市場規模・分析
・再生医学の北米市場規模・予測
・再生医学のアメリカ市場規模・予測
・再生医学のヨーロッパ市場規模・予測
・再生医学のアジア市場規模・予測
・再生医学の日本市場規模・予測
・再生医学の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global Regenerative Medicine Market valued approximately USD 49.68 billion in 2018 is anticipated to grow with a healthy growth rate of more than 24.2% over the forecast period 2019-2026. The Regenerative Medicine Market is continuously growing in the global scenario at significant pace. Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Stem cells are capable of proliferation and differentiation, which increase their importance in this field. Government & private funding to support the development of regenerative medicine, surging prevalence of chronic diseases & genetic disorders, escalating healthcare expenditure and rising geriatric population are the substantial driving factors of the market during the forecast period. Moreover, surging demand for organ transplantation and rising advancements in regenerative medicine is the factors that likely to create numerous opportunity in the near future. However, lack of clear regulatory guidelines and high cost of the treatment through the use of regenerative medicine are the factors that limiting the growth of the market during the forecast period.
The regional analysis of Global Regenerative Medicine Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share with nearly 31.3% due to rapid technological advancements and high investment & funding to support development of regenerative medicines in the region. Europe is also estimated to grow at stable growth rate in the global Regenerative Medicine market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to rising development of healthcare infrastructure and presence of large number of patients in the region.

The major market player included in this report are:
Acelity L.P. Inc.
Nuvasive Inc.
Vericel Corporation
Osiris Therapeutics Inc.
Stryker Corporation
Medtronic PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

Stem Cell Therapy
Biomaterial
Tissue Engineering
Others

By Application:

Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Others

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Regenerative Medicine Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Regenerative Medicine Market, by Technology, 2016-2026 (USD Billion)
1.3.2. Regenerative Medicine Market, by Application, 2016-2026 (USD Billion)
1.3.3. Regenerative Medicine Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Regenerative Medicine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Regenerative Medicine Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Regenerative Medicine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Regenerative Medicine Market, by Technology
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. Regenerative Medicine Market, Sub Segment Analysis
5.4.1. Stem Cell Therapy
5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2. Biomaterial
5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.3. Tissue Engineering
5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.4. Others
5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Regenerative Medicine Market, by Application
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. Regenerative Medicine Market, Sub Segment Analysis
6.4.1. Bone Graft Substitutes
6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.2. Osteoarticular Diseases
6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.3. Dermatology
6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.4. Cardiovascular
6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.5. Central Nervous System
6.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.6. Others
6.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Regenerative Medicine Market, by Regional Analysis
7.1. Regenerative Medicine Market, Regional Market Snapshot (2016-2026)
7.2. North America Regenerative Medicine Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3. Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3. Europe Regenerative Medicine Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3. Rest of Europe
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4. Asia Regenerative Medicine Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5. Latin America Regenerative Medicine Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Acelity L.P. Inc.
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Summary
8.3.1.4. Recent Developments
8.3.2. Nuvasive Inc.
8.3.3. Vericel Corporation
8.3.4. Osiris Therapeutics Inc.
8.3.5. Stryker Corporation
8.3.6. Medtronic PLC
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF REGENERATIVE MEDICINE MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF REGENERATIVE MEDICINE MARKET
TABLE 3. REGENERATIVE MEDICINE MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
TABLE 8. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 9. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43. REGENERATIVE MEDICINE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. REGENERATIVE MEDICINE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. U.S. REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. CANADA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. UK REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 61. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 62. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 64. GERMANY REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 65. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 66. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 67. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 68. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 69. ROE REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 70. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 71. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 72. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 73. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 74. CHINA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 75. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 76. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 77. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 78. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 79. INDIA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 80. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 81. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 82. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 83. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 84. JAPAN REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 85. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 86. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 87. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 88. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 89. ROAPAC REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 90. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 91. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 92. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 93. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 94. BRAZIL REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 95. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 96. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 97. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 98. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 99. MEXICO REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 100. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 101. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 102. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 103. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 104. ROLA REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 105. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 106. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 107. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 108. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 109. ROW REGENERATIVE MEDICINE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures
FIG 1. REGENERATIVE MEDICINE MARKET, RESEARCH METHODOLOGY
FIG 2. REGENERATIVE MEDICINE MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. REGENERATIVE MEDICINE MARKET, KEY TRENDS 2017
FIG 5. REGENERATIVE MEDICINE MARKET, GROWTH PROSPECTS 2018-2026
FIG 6. REGENERATIVE MEDICINE MARKET, PORTERS 5 FORCE MODEL
FIG 7. REGENERATIVE MEDICINE MARKET, PEST ANALYSIS
FIG 8. REGENERATIVE MEDICINE MARKET, VALUE CHAIN ANALYSIS
FIG 9. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 15. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 16. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 17. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 18. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 19. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 20. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 21. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 22. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 23. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 24. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 25. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 26. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 27. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 28. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 29. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 30. REGENERATIVE MEDICINE MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 31. REGENERATIVE MEDICINE MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 32. NORTH AMERICA REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
FIG 33. EUROPE REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
FIG 34. ASIA PACIFIC REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
FIG 35. LATIN AMERICA REGENERATIVE MEDICINE MARKET 2016 & 2026 (USD BILLON)
FIG 36. REGENERATIVE MEDICINE MARKET, COMPANY MARKET SHARE ANALYSIS (2017)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[再生医学の世界市場:技術別(幹細胞療法、バイオマテリアル、組織工学、その他)、用途別(骨移植代用品、骨関節疾患、皮膚病学、心血管、中枢神経系、その他)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆